Janney sees upside for Durata Therapeutics, Impax Labs

Janney Montgomery starts Durata Therapeutics (DRTX) and Impax Laboratories (IPXL) at Buy.

Price targets: $19 for DRTX and $30 for IPXL.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs